Could stem cell 'Bubbles' help damaged lungs? new study begins
NCT ID NCT07570836
First seen May 07, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This early-stage study tests the safety of a new treatment for interstitial lung disease (ILD), a group of conditions that cause lung scarring and breathing problems. The treatment uses tiny particles called extracellular vesicles, derived from stem cells, which are inhaled as a mist. Twenty-four adults with ILD will receive either the active treatment or a placebo (saltwater mist) to see if it is safe and if it might improve lung function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.